The Boston Business Journal reported in June that the biopharmaceutical company was negotiating a lease to move out of its current headquarters in East Cambridge for 830 Winter St. in Waltham, Mass. ImmunoGen, which develops novel targeted anticancer therapeutics, will occupy office and laboratory space on each of three floors at 182,106-square-foot building.
"ImmunoGen is excited to have the opportunity to bring all of our research operations into a single facility along with our corporate offices," said Daniel M. Junius, chief financial officer of ImmunoGen Inc., in a statement. "We think 830 Winter St. is ideally suited to our needs and will provide us high-quality lab and office space for many years."
ImmunoGen (Nasdaq:IMGN - News) was represented in the lease by T3 Advisors LLC and the landlord, Intercontinental Real Estate, was represented by Richards Barry Joyce & Partners LLC.
